The GBP2 promoter methylation in circulating DNAmay be considered as a possible effective non-invasive molecular marker in poorprognostic breast cancer patients with the evidence of its relation to disease stageand lymph node metastasis. This evidence concerns the gene GBP2 and breast cancer.